Download This PaperFDA's Proposed Changes to Generic Drug Label Rules Questioned by Members of Congress
Health Reform Watch, January 2014
2 Pages Posted: 3 Apr 2014
Date Written: January 29, 2014
Abstract
This blog entry discusses the FDA's proposed regulation published in November 2013 that would allow generic drug manufacturers to make labeling changes in the wake of Mutual Pharmaceuticals v. Bartlett and Pliva v. Mensing.
Keywords: generic drugs, labeling, proposed regulation, FDA, Supreme Court
Suggested Citation: Suggested Citation
Paradise, Jordan K., FDA's Proposed Changes to Generic Drug Label Rules Questioned by Members of Congress (January 29, 2014). Health Reform Watch, January 2014, Available at SSRN: https://ssrn.com/abstract=2419638
Feedback
Feedback to SSRN
If you need immediate assistance, call 877-SSRNHelp (877 777 6435) in the United States, or +1 212 448 2500 outside of the United States, 8:30AM to 6:00PM U.S. Eastern, Monday - Friday.